[{"AccountsPayableCurrent_0_Q1_USD":1956000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-695000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-2248000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":93056000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":515000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":7.12,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":33000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":1185000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":1100000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":4491000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":200000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-44668000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":876815000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-2118000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":18.97,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":1185000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":293295.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":23.05,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":4358640.0,"DepreciationDepletionAndAmortization_1_Q1_USD":2809000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":1184000.0,"StockGrantedDuringPeriodValueSharebasedCompensation_1_Q1_USD":162000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":21.04,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":73003000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":61186000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":56000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":26615000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3088000.0,"Investments_0_Q1_USD":77793000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":7306954.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":8100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-33416000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":77793000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":77721000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":27000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":99000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":4451000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q1_USD":72000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":515000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":9506000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q1_USD":3700000.0,"OtherAssetsNoncurrent_0_Q1_USD":23810000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":11.49,"NetIncomeLoss_1_Q1_USD":-44724000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-44142000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":10564000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":162000.0,"LiabilitiesCurrent_0_Q1_USD":39610000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":265413000.0,"Liabilities_0_Q1_USD":74840000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-938000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1253000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_1_Q1_USD":-2286000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.91,"CostsAndExpenses_1_Q1_USD":59127000.0,"CommonStockValue_0_Q1_USD":492000.0,"CommonStockSharesOutstanding_0_Q1_shares":49131150.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":93056000.0,"AssetsCurrent_0_Q1_USD":195285000.0,"Assets_0_Q1_USD":265413000.0,"AccountsReceivableNetCurrent_0_Q1_USD":11806000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":10233000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":190573000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-686806000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":0.94,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":20.95,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":7644939.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1_Q1_shares":1403627.0,"PrepaidExpenseCurrent_0_Q1_USD":12630000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":721000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":1345000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":172387.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":46318000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":48894000.0,"OperatingIncomeLoss_1_Q1_USD":-45445000.0,"CommonStockSharesAuthorized_0_Q1_shares":125000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"AccruedLiabilitiesCurrent_0_Q1_USD":25060000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":49012663.0,"StockholdersEquity_0_Q1_USD":190573000.0,"Revenues_1_Q1_USD":13682000.0,"ShareBasedCompensation_1_Q1_USD":4491000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":56000.0,"Ticker":"MGNX","CIK":"1125345","name":"MACROGENICS INC","OfficialName":"MacroGenics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"504089511.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200505"}]